Publication:
Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study

Thumbnail Image

Date

Organizational Units

Authors

Çavuşoğlu, İlkin

Authors

Şeftalioğlu, Aysel
Karakuş, Sema
Dündar, Semra
Can, Belgin
Erdemli, Esra
Irmak, Mehmet Kemal
Öztaş, Emin
Korkmaz, Cem
Yazar, Fatih

Advisor

Language

Publisher:

Taylor and Francis

Journal Title

Journal ISSN

Volume Title

Abstract

Syndecan-1 (CD138), an important transmembrane heparan sulfate proteoglycan is expressed in distinct stages of cell differentiation. Although its expression in acute lymphoblastic leukemia (ALL) cells is well known; its function or presence in acute myeloblastic leukemia (AML) cells is still largely unknown. The expression of syndecan-1 was studied in bone marrow biopsies of three patients with AML using electron microscopic immunocytochemistry. Positive expression of syndecan-1 was found in AML cells. These results suggest that syndecan-1 expression is not only a characteristic phenotypic marker for ALL, but is also expressed in AML cells.

Description

Source:

Keywords:

Keywords

Oncology, Heparan-sulfate proteoglycan, Acute lymphoblastic-leukemia, Bone-marrow, Stroma, Molecular-cloning, Migration, Adhesion, Biopsy, Bone, Cells, Electron microscopy, Myeloblastic leukemia cells, Tumors

Citation

Şeftalioğlu, A. vd. (2003). “Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study”. Acta Oncologica, 42(1), 71-74.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads